Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.

Key facts

Study ID

NCT00434395

Run by

Bausch Health Americas, Inc.

Starts

2007-03-01

Expected to finish

2007-10-01

Last updated by the study team

2019-11-25

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Generally healthy subjects men or women aged 18-50

You may not qualify if…

• Any significant clinically important disease
• Family history of long QT syndrome and/or sudden cardiac death
• Allergy to moxifloxacin or the quinolone class of antibiotics

Where it is running

• Study site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.